173 related articles for article (PubMed ID: 25871297)
1. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
3. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
[TBL] [Abstract][Full Text] [Related]
4. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.
Chen SH; Tan SL
Curr Med Chem; 2005; 12(20):2317-42. PubMed ID: 16181135
[TBL] [Abstract][Full Text] [Related]
5. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
[TBL] [Abstract][Full Text] [Related]
6. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease.
Yang L; Lin J; Zhou B; Liu Y; Zhu B
Nat Prod Res; 2017 Feb; 31(4):487-491. PubMed ID: 27295355
[TBL] [Abstract][Full Text] [Related]
7. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
9. Potent aza-peptide derived inhibitors of HCV NS3 protease.
Venkatraman S; Wu W; Shih NY; George Njoroge F
Bioorg Med Chem Lett; 2009 Aug; 19(16):4760-3. PubMed ID: 19596195
[TBL] [Abstract][Full Text] [Related]
10. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
11. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease.
Zuo G; Li Z; Chen L; Xu X
Antiviral Res; 2007 Oct; 76(1):86-92. PubMed ID: 17624450
[TBL] [Abstract][Full Text] [Related]
12. In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus.
Javed T; Ashfaq UA; Riaz S; Rehman S; Riazuddin S
Virol J; 2011 Jan; 8():26. PubMed ID: 21247464
[TBL] [Abstract][Full Text] [Related]
13. An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
Pause A; Kukolj G; Bailey M; Brault M; Dô F; Halmos T; Lagacé L; Maurice R; Marquis M; McKercher G; Pellerin C; Pilote L; Thibeault D; Lamarre D
J Biol Chem; 2003 May; 278(22):20374-80. PubMed ID: 12646587
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
Yang CM; Yoon JC; Park JH; Lee JM
PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
[TBL] [Abstract][Full Text] [Related]
16. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Anti-HCV Activity of Multiple Punica granatum Extracts and Fractions in Virus-infected Human Hepatocytes.
Rehman S; Ashfaq UA; Ijaz B; Jabeen Z; Riazuddin S
Curr Pharm Biotechnol; 2018; 19(15):1221-1231. PubMed ID: 30608038
[TBL] [Abstract][Full Text] [Related]
19. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
[TBL] [Abstract][Full Text] [Related]
20. Peptidic inhibitors of the hepatitis C virus serine protease within non-structural protein 3.
Fischmann TO; Weber PC
Curr Pharm Des; 2002; 8(28):2533-40. PubMed ID: 12369938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]